发明名称 NILOTINIB INTERMEDIATES AND PREPARATION THEREOF
摘要 Intermediates of Nilotinib were prepared, including, for example, 3-(trifluoromethyl- 5 -(4-methyl- 1 H-imidazole- 1 -yl)-benzeneamine; 3 -(4-(pyridin-3 -yl)pyrimidin-2-ylamino)-4- methylbenzoyl halogen dihydrochloride; and N-(3-Bromo-5-trifluoromethylphenyl)-4- methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide. Nilotinib»3HCl and its crystalline forms are also described.
申请公布号 WO2010009402(A3) 申请公布日期 2010.08.26
申请号 WO2009US51001 申请日期 2009.07.17
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;WANG, YANLING;LI, JIE;KANSAL, VINOD, KUMAR;ZHU, JIRANG;LIFSHITZ-LIRON, REVITAL;MISTRY, DHIRENKUMAR, N.;VASOYA, SANJAY, L.;ARIYAMUTHU, SUNDARASELVAN;PILARSKI, GIDEON;HE, XUNGUI 发明人 WANG, YANLING;LI, JIE;KANSAL, VINOD, KUMAR;ZHU, JIRANG;LIFSHITZ-LIRON, REVITAL;MISTRY, DHIRENKUMAR, N.;VASOYA, SANJAY, L.;ARIYAMUTHU, SUNDARASELVAN;PILARSKI, GIDEON;HE, XUNGUI
分类号 C07D233/61;C07D401/04;C07D401/14 主分类号 C07D233/61
代理机构 代理人
主权项
地址